A subgroup analysis of the nationwide, cross-sectional 3B STUDY was performed to understand the current blood pressure (BP) control status and treatment patterns in Chinese diabetes patients as well as to identify factors associated with BP control. The demographic data, anthropometric parameters, and laboratory results were collected from 24 512 type 2 diabetes patients. The BP goal was a systolic BP <130 mm Hg and a diastolic BP <80 mm Hg regardless of a history of hypertension or current antihypertensive treatment. The overall prevalence of hypertension was 59.9% with geographical differences. Among the diabetes patients with hypertension, 76.9% received antihypertensive medicines. Calcium channel blockers (39.3%), angiotensin II receptor antagonists (26.6%), and then β-blockers (14.0%) or angiotensin-converting enzyme inhibitors (13.6%) were frequently used for BP control. Only 17.5% (n = 2658) of diabetes patients with hypertension reached the recommended target BP. Body mass index <24 kg/m 2 , urban resident, frequent physical activity, good adherence to medication, comorbidity with cardiovascular disease, achieving glycemic goal (HbA1c <7.0%), achieving lipid goal (low-density lipoprotein cholesterol <2.59 mmol/L) were independent factors that predicted achievement of target BP goal. On the contrary, comorbidity with chronic kidney disease predicted failure to achieve target BP goal. Patients who were treated in a cardiology department or lived in the North were more likely to achieve BP goals. A considerable proportion of diabetic patients failed to achieve guideline-recommended BP targets. More aggressive efforts should be made to overcome the diverse barriers and facilitate the optimization of diabetes management. S U PP O RTI N G I N FO R M ATI O N Additional supporting information may be found online in the Supporting Information section at the end of the article. How to cite this article: Zhang Y-Q, Li Y, Dong Y-G, et al. A nationwide assessment of blood pressure control and the associated factors in Chinese type 2 diabetes mellitus patients.
| INTRODUC TI ON
Type 2 diabetes mellitus (T2DM) is a highly prevalent and progressive chronic disease, affecting 92.4 million adults in China according to a nationwide survey. 1 With the increasing prevalence of obesity and aging population, DM has become one of the most challenging diseases threatening public health in China. Hypertension is the most frequent comorbidity, with approximately 60%-75% of diabetes patients also having hypertension. 2, 3 Hypertension directly damages the microvasculature, leading to small vessel dysfunction. 4 The presence of hypertension aggravates the progression of diabetic complications such as nephropathy and retinopathy and also increases the risks of stroke, cardiovascular disease (CVD), and all-cause death. [3] [4] [5] [6] Cardiovascular death accounts for approximately two-thirds of all deaths in diabetic patients, with hypertension being responsible for up to 75% of CVD in diabetics. 7, 8 Thus, optimizing blood pressure (BP) management to control BP is significantly important for these patients.
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The BP goal for T2DM patients is less than 130/80 mm Hg as recommended by both the Chinese hypertension management guideline and China guideline for type 2 diabetes (2013) as well as the American Diabetes Association's (ADA's) Standards of Care. 9, 10 According to international hypertension management guidelines, T2DM patients with hypertension are recommended to initiate antihypertensive treatment when the systolic blood pressure (SBP) ≥140 mm Hg and/or diastolic blood pressure (DBP) ≥90 mm Hg and to achieve their BP goal promptly. 11 However, the current control rate of BP in T2DM patients is poor in China. In an observational, cross-sectional study published in 2010, which enrolled 5086 treated hypertensive patients from outpatient clinics in Chinese tier 3 hospitals, the BP control rate was only 14.9% in 1891 diabetes patients with hypertension. 12 A recent study in type 2 diabetes patients has shown that even with intensive management, achievement of target BP is difficult for significant numbers of patients. 13 However, there is a paucity of data regarding the treatment pattern and consequently BP control in a large T2DM population. Furthermore, little is known about the modifiable risk factors for BP control. We evaluated the control of BP in T2MD patients from the Nationwide Assessment of Cardiovascular Risk Factors: Blood
Glucose, Blood Pressure, and Blood Lipid (CCMR-3B) study, a large, cross-sectional investigation of Chinese patients with T2DM.
Knowledge of current trend of BP control and medication use in diabetes patients can be useful for the upcoming China Hypertension Guideline revision. In addition, identifying and managing modifiable factors that favor BP control will facilitate the optimization of diabetes management and improvement of long-term outcomes.
| ME THODS

| Study design and participants
The CCMR-3B STUDY was an observational, cross-sectional, multicenter, multispecialty study of outpatients diagnosed T2DM more than 6 months according to the World Health Organization criteria. 14 The study design and population have been previously described [NCT01128205]. [15] [16] [17] Patients with type 1 diabetes, and who were pregnant, or participating in other clinical study were not included.
Each patient signed an informed consent form.
| Data collection
Patient data were collected from medical charts and clinical examinations were conducted at outpatient visits. Patients' information, including age, gender, residential region, health behaviors (ie, smoking status/habit, alcohol consumption, and exercise), current medications, medication adherence, and personal history of hypertension, dyslipidemia, and major CVDs as well as family history were obtained by self-reporting during a face-to-face interview. Physical examination included anthropometry and BP measurements. Office BP levels were determined by taking two consecutive measurements with an automated BP monitor after a 5-min rest in the sitting or supine position, with a minimum 2-min interval between readings. The average value of two blood pressure measurements was obtained for analysis. Height and weight were measured with patients standing with bare feet and light clothing on a mechanical balance. Laboratory measurements including glycosylated hemoglobin (HbA1c) and low-density lipoprotein cholesterol (LDL-c), and highdensity lipoprotein cholesterol (HDL-c) were processed during the 3 months prior to the enrollment visit or measured at each study site during the outpatient visits were recorded.
| Definition of variables
In China, hypertension is defined as office SBP values ≥140 mm Hg and/or diastolic BP (DBP) values ≥90 mm Hg. In this study, hypertension was defined as a documented diagnosis of hypertension and/or current use of antihypertensive agents. Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters (kg/m 2 ). Smoking was defined as consuming an average of at least one cigarette daily for at least 1 year. 15, 16, 18 Alcohol intake was defined as consuming an average at least 50 g of alcohol daily for at least 1 year. 15, 16 A sedentary lifestyle was defined as not participating in regular physical activities or daily exercise less than 30 minutes. Medical compliance/adherence was reported by the patients using a questionnaire. Good adherence was defined as >80% days covered by prescribed target medications during a 6-month period.
Cardiovascular disease was defined as stable or unstable angina, myocardial infarction, undergoing percutaneous coronary intervention, or undergoing coronary bypass. Cerebrovascular disease (CBD) was defined as ischemic stroke, hemorrhagic stroke, or transient ischemic attack. Chronic kidney disease (CKD) was defined as kidney damage (eg, proteinuria) or glomerular filtration rate (GFR) <60 mL/ min/1.73 m 2 for 3 months or more, irrespective of cause. Diabetic retinopathy, nephropathy, and neuropathy were recorded only if a well-documented diagnosis was available.
The BP goal was a SBP <130 mm Hg and a DBP <80 mm Hg regardless of a history of hypertension or current antihypertensive treatment. According to the China Guidelines for Type 2 Diabetes, the glycemic goal was defined as HbA1c <7% and the lipid goal was defined as LDL-C <2.59 mmol/L. 19 
| Statistical analysis
The spss for Windows version 20.0 software package (SPSS Inc,) was used for statistical data analysis. Continuous data are expressed as mean ± SD for data that were normally distributed and median with interquartile range for data that were not normally distributed. Categorical data are presented in terms of absolute values and percentages. Continuous variables were analyzed using Student's t test and ANOVA. Categorical variables were analyzed using the chi-squared test and Fisher's exact test. A multivariable logistic regression analysis was conducted to identify associations between dependent and independent variables. The results are expressed as adjusted odds ratios (ORs) with 95% confidence intervals (95% CIs). Statistical significance was accepted as a two-sided test with an alpha level of 0.05. All enrolled patients were identified by participant number in the database to ensure anonymity. Patients with hypertension were more likely to be older, female, and an urban resident, but less likely to be a current drinker; they also had a higher BMI and longer duration of diabetes compared with normotensive patients (P < .001). Significant geographical differences were found in the prevalence of hypertension.
| RE SULTS
| Baseline characteristics of participants
| Medication regimens
The numbers and percentages of patients receiving pharmaceutical treatment for hypertension are shown in Table S1 . Among T2DM patients without a history of hypertension, only a few received antihypertensive drug therapy (36 of 10 217 received beta-blockers, 15 received calcium channel blockers, 12 received angiotensin-converting enzyme (ACE) inhibitors, and 8 received angiotensin II receptor antagonists). Among 15 211 diabetes patients with hypertension, 76.9% (n = 11 690) received antihypertensive medicines. The most frequently used oral antihypertensive agents were calcium channel blockers (39.3%), followed by angiotensin II receptor antagonists (26.6%), beta-blockers (14.0%), and ACE inhibitors (13.6%). Notably, patients who failed to achieve the recommended BP goal used more types of antihypertensive medicines. Table S2 .
| BP control in T2DM patients with hypertension
For patients with hypertension, age >65 years, current smoking or alcohol intake, sedentary lifestyle, BMI ≥24 kg/m 2 , diabetic complications (CVD and CKD), poor medical adherence, poor control of blood glucose (HbA1c ≥7.0%), and poor control of blood lipids (LCL-C ≥2.59 mmol/L) were associated with a significant decrease in BP goal (<130/80 mm Hg) attainment rate ( Table 2) 
. Patients in southwest
China had the highest BP control rate, whereas those in the northeast had the lowest BP control rate. Patients treated in a cardiology department were more likely to achieve the BP goal, whereas patients treated in a nephrology department were less likely to achieve the target BP.
Adequate control of BP in diabetes patients with hypertension was further analyzed by HbA1c stratification (Table S3 ). Patients from the northeast or who had a BMI ≥24 kg/m 2 were unlikely to achieve the target BP, irrespective of HbA1c level. Patients who drank alcohol exhibited a low BP attainment rate when their HbA1c was between 6.0% and 8.0%. With respect to comorbidities, patients with CVD were more likely to achieve the BP goal, independent of the HbA1c level, whereas patients with CKD and a low HbA1c (<7.0%) exhibited a reduced BP control rate. Patients with high LDL levels (>2.59 mmol/L) were less likely to achieve the target BP, especially when they had a high HbA1c level (>6.0%).
| Factors associated with BP control in diabetes patients with hypertension
Logistic regression analysis showed that BMI <24 kg/m 2 (OR 1.31, 95% CI 1.19-1.46, P < .001), urban residence (OR 1.32, 95% CI 1.11-1.58, P = .002), frequent physical activity (OR 1.12, 95% CI 1.01-1.25, P = .031), good medication adherence (OR 1.29, 95% CI 1.09-1.53, P = .003), comorbidity with CVD (OR 1.32, 95% CI 1.16-1.50, P < .001), HbA1c <7.0% (OR 1.33, 95% CI 1.20-1.48, P < .001), LDL-C <2.59 mmol/L (OR 1.11, 95% CI 1.00-1.22, P = .049) predicted achievement of the BP goal ( Table 3 ; Table S4 ). In contrast, comorbidity with CKD (OR 0.77, 95% CI 0.67-0.87, P < .001) predicted failure to achieve the target BP. Interestingly, relative to patients treated in a nephrology department or living in the northeast, those patients treated in a cardiology department (OR 1.30, 95% CI 1.05-1.61) or living in the north (OR 3.56, 95% CI 2.85-4.45) were more likely to achieve the BP goal. In addition, a short hypertension duration less than 1 year was an unfavorable factor for BP control.
| Association of BP with stroke/coronary heart disease
The prevalence rates of self-reported stroke, coronary heart disease, and CKD in the diabetes patients with hypertension were 12.3%, 20.6%, and 20.2%, respectively. The distributions of stroke, coronary heart disease, and CKD based on BP stratification are shown in Figure 1 . Also, the associations of BP and diabetes complications were analyzed (Table S5 ). In the fully adjusted models, SBP between 120 and 130 mm Hg was associated with less chance of CKD devel- was found to be associated with a high likelihood of development of coronary heart disease and CKD.
| D ISCUSS I ON
Hypertension is extremely widespread in T2DM patients. A previous study reported an average 10%-22% reduction in coronary heart disease events and 41% reduction in strokes with a SBP reduction of 10 mm Hg or DBP reduction of 5 mm Hg, indicating the importance of BP control for the prevention of CVD. 20 Overall, the rates of hypertension control have varied from 13.85% to 54% in different diabetic populations. 21 In this study, only 17.5% of diabetic participants with hypertension achieved the recommended BP goal, suggesting that there is much room for improvement.
The prevalence of hypertension varies geographically within
China. 22 Based on another national survey, the epidemic of hypertension in China is most severe in the east region (32.6%) followed by the northeast region (31.8%). 23 in the southwest vs 7.2% in the northeast). One reason for this trend may be that residents in the rural or economically poorer northeast region were more likely to be unaware the importance of antihypertensive management. Climate, lifestyle, and diet might also contribute to the unacceptably low control rate of hypertension in the northeast region, especially among diabetes patients with hypertension. This has important implications for targeting intervention strategies and government expenditure aimed to prioritize populations in geographical regions with a high prevalence and low control such as in northeast China.
The BP control rate gradually decreased with the increase of age in the overall diabetic population, which is consistent with a previous study. 24 Unexpectedly, diabetes patients with hypertension and age >65 years had a relatively higher attainment rate, probably because the elderly had adequate time and care for BP management after their retirement, whereas young people are busier with working and socializing. In addition, BP control rate did not significantly differ by gender. However, failure to achieve the BP goal may be related to smoking and alcohol intake in diabetes patients with hypertension.
It has been reported that the increased prevalence of hypertension in T2DM patients is directly associated with escalating rates of overweight and obesity. 25 Obesity, hypertension, and insulin resistance often occur in concert to increase the risk of diabetes, which further interact in a vicious cycle, resulting in poor control of both BP and glycemia. 26 In this study, BMI ≥24 kg/m 2 was associated with a decline in the BP attainment rate in diabetes patients, independent of the presence of hypertension or HbA1c levels. In addition, BMI <24 kg/m 2 and frequent activity were independent favorable factors for BP control. To reduce cardiovascular risks, sedentary patients with T2DM were advised to participate in at least 150-minute moderate-intensity physical activity per week. 27 Investigating the barriers, such as feeling too unfit, too tired, and too fat that contribute to the propensity of being physically inactive is important to improve the BP attainment rate.
Diabetes patients treated in a nephrology department exhibited the worst BP control, probably due to a high prevalence of resistant hypertension in patients with renal dysfunction. In a study, the investigators analyzed a sample of 116 777 outpatients and found that CKD and its components, mainly high albuminuria, were associated with failure to reach BP target, despite a greater use of drugs in patients with T2DM. 28 Interestingly, among diabetes patients with hypertension, patients with CVD were more likely to achieve the target BP goal than those without. This may be related to stronger awareness of BP management and frequent visits to cardiology clinics. Notably, uncontrolled hypertension has been considered a result of a lack of adherence to therapy and lack of awareness of the harm of uncontrolled hypertension. 29 Therefore, clinicians should recognize that patients need not only short-term, intensive BP reduction but also long-term adherence and maintenance of lower BP levels.
Complex, multifactorial mechanisms have been put forward to explain the high frequency of hypertension in T2DM patients, including the sympathetic stimulant effects of hyperinsulinemia, activation of the renin-angiotensin system (RAS), hyperglycemia-induced oxidative stress/endothelial damage, and sodium-fluid retention. 30 of the BP goal in diabetes patients, indicating the significance of simultaneous management of BP, lipid, and glucose levels.
Although high BP is associated with increased risks of CVD and death in the general population, low BP (for instance, BP <120/70 mm Hg) has been shown to be paradoxically associated with increased risks of coronary heart disease and even mortality in diabetes patients, 32, 33 particularly in the elderly and those with concomitant coronary artery disease, CKD. 34 The underlying mechanism for this phenomenon is unclear. In addition, according to the results of the ACCORD trial, intensive BP treatment (targeting BP goal <120/80 mm Hg) does not improve cardiovascular outcomes (myocardial infarction, stroke, cardiovascular death, etc) in diabetes patients. 35 However, intensive BP treatment led to a lower annual rate of stroke (0.32%, HR 0.59; P = .01), in contrast to standard-therapy (0.53%), indicating a benefit of intensive BP treatment for stroke occurrence. This is especially important in China a country with increased burden of stroke over the past 30 years. 36 Consistently, in this study, low DBP (<70 mm Hg) was found to be associated with a high likelihood of the development of coronary heart disease or CKD.
In the SPRINT study, for subjects without CKD at baseline, the incidence of the outcome defined by a decrease in the eGFR of 30% or more to a value of less than 60 mL/min/1.73 m 2 was higher in patients receiving intensive-treatment than those with standard-treatment (1.21% per year vs 0.35% per year; HR 3.49; P < .001). 37 For the studied population of diabetes patients, most of whom were elderly, targeting unreasonable low BPs may carry risks of adverse events.
Also, we found that a SBP between 120 and 130 mm Hg was associated with a lower chance of CKD development in diabetic patients.
Further evidence is needed to confirm the observational results, because this was a study with a cross-sectional design. proven the advantages of early BP reduction for cardiovascular outcomes. [40] [41] [42] The post hoc analysis of the VALUE study showed that cardiovascular event was reduced in patients who achieved BP control (<140/90 mm Hg) within 1 month, regardless of the type of treatment, compared with that in those who did not. 42 aggressive antihypertensive therapy including initial or early combination to help improve their outcomes.
Our study has several strengths. First, this was the largest nationwide survey to illustrate the BP control in T2DM patients in varying distinct geographic regions of China, which made our sample representative. Second, the proportion of diabetes patients who achieved BP control was analyzed with HbA1c stratification, which provided more detailed evidence for identifying the populations less likely to achieve BP control. This study has some limitations. First, it was a cross-sectional study, which made it difficult to confirm causal relationships between clinical variables and failure to achieve the BP goal. Secondly, medication adherence was self-reported by the patients using a questionnaire, thus a bias may have existed. Thirdly, we did not evaluate the awareness of hypertension in this diabetic population. In addition, the potential influence of some unmeasured confounding factors on the observed association cannot be entirely ruled out.
In conclusion, hypertension is highly prevalent among diabetes patients in China, with varying geographical differences. A considerable proportion of Chinese diabetes patients failed to achieve guideline-recommended BP goal, and such failure was more pronounced among those who were overweight, a rural resident, living in the northeast as well as among those with CKD, poor medication adherence, and uncontrolled hyperglycemia or dyslipidemia. More aggressive efforts should be made to overcome the diverse barriers for glycemic and BP control. 
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R E FE R E N C E S
F I G U R E 1 Distributions of stroke, coronary heart disease, and Chronic kidney disease (CKD) according to systolic blood pressure (SBP) and diastolic blood pressure (DBP) stratification. Patients with SBP between 130 and 140 mm Hg, and DBP between 70 and 90 mm Hg were most likely to have a history of stroke, coronary heart disease, and CKD. SBP, systolic blood pressure; DBP, diastolic blood pressure; CKD, chronic kidney disease
